Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Advanced Renal Cell Carcinoma · Advanced Mesothelioma · Advanced Osteosarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

M D Anderson Cancer Center, Houston, Texas, United States
Contact: Study coordinator (David Hong, MD) · dshong@mdanderson.org · 713-563-5844
Contact: Principal Investigator (David Hong, MD)

Study leads

David Hong, MD
Principal Investigator
M.D. Anderson Cancer Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Agnostic Therapy in Rare Solid Tumors

Urachal Cancer · Parathyroid Carcinoma · Fibrolamellar Carcinoma

Abroad (travel likely)RecruitingPHASE2

Fortaleza, Brazil · Salvador, Brazil

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

Renal Cell Carcinoma

Abroad (travel likely)RecruitingPHASE2

Irvine, United States · Boston, United States

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Advanced Anal Carcinoma · Advanced Biliary Tract Carcinoma · Advanced Bladder Carcinoma

Abroad (travel likely)RecruitingPHASE2

Jacksonville, United States · Grand Forks, United States

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Advanced Cancer · Advanced Solid Tumor · Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Aurora, United States · Lake Mary, United States